EBD Events

Sean Knight, Senior Director, Business Development, Simtra BioPharma Solutions, discusses the company’s expansion plans.
Outsourcing
Going to Market with Simtra BioPharma SolutionsGoing to Market with Simtra BioPharma Solutions
byBIO-Europe 2024
Dec 19, 2024
3 Min View
Hervé Ansanay, Biotech Alliance Manager, discusses the features of the RESEAU SATT - SATT NETWORK
Hubs
RESEAU SATT, the Best of French Deep TechRESEAU SATT, the Best of French Deep Tech
byBIO-Europe 2024
Dec 18, 2024
3 Min View
Janet Hoogstraate, CEO, NorthX Biologics discusses the CDMOs capabilities and expertise.
Outsourcing
NorthX Biologics is Beyond CDMO
NorthX Biologics is Beyond CDMO
Dec 18, 2024
|
4 Min View
byBIO-Europe 2024
Simon Fagg, Founder of coaching and training organization With Leadership
Best Practices
Tips Toward a Better Presentation
Tips Toward a Better Presentation
Dec 18, 2024
|
3 Min View
byBIO-Europe 2024
Alex Fink, Senior Vice President, and Ed Salzman, Senior Strategic Advisor, both with Lumanity, discuss commercial readiness of biotechs
Scaling/Commercialization
Biopharma Dealmaking and Commercialization Readiness: Time for a Rethink?
Biopharma Dealmaking and Commercialization Readiness: Time for a Rethink?
Dec 18, 2024
|
9 Min View
byBIO-Europe 2024
Michael May, PhD, President, CCRM discusses Canada as a place for life sciences in this video.
Hubs
Bridging AI & Life Sciences, Why Investing in Canada Should Be Your Next Move
Bridging AI & Life Sciences, Why Investing in Canada Should Be Your Next Move
Dec 18, 2024
|
8 Min View
byBIO-Europe 2024
Walter Boyle, Global Head of Axio, Cytel Inc., BIO-Europe 2024
Sponsored Content
Why are DMCs Important to Clinical Development?
Why are DMCs Important to Clinical Development?
Dec 17, 2024
|
4 Min View
byBIO-Europe 2024
@Informa BIO-Europe 2024, CEO of Cellevate interview
Scaling/Commercialization
Scale Up and Boost Your Viral Vector Production
Scale Up and Boost Your Viral Vector Production
Dec 17, 2024
|
4 Min View
byBIO-Europe 2024
Novo Nordisk sign
Business Strategy
Lessons and blessings: The Novo Nordisk way
Lessons and blessings: The Novo Nordisk way
Nov 22, 2024
|
2 Min Read
byMillie Nelson, Editor
Shaking hands
Partnering
Picky pharma prone to better proven partners amid dealmaking downturn
Picky pharma prone to better proven partners amid dealmaking downturn
Nov 19, 2024
|
3 Min Read
byMillie Nelson, Editor
Panelists Anta Gkelou Partner, Sofinnova Partners; Bobby Soni CIO, BioInnovation Institute; Renee Lucander CEO, Calliditas Therapeutics
Partnering
Successful mentorship between investors and CEOs hangs on respect
Successful mentorship between investors and CEOs hangs on respect
Nov 15, 2024
|
5 Min Read
Seed Funding
Europe’s adversity to risk is why the US is ahead, say experts
Europe’s adversity to risk is why the US is ahead
Nov 5, 2024
|
3 Min Read
byMillie Nelson, Editor
photo of a sunrise over solar panels/building
Innovation
Inside five innovative research companies driving progress in oncology and neurology
Driving progress in oncology and neurology
Sep 21, 2024
|
9 Min Read
Chinese flag — Photo
Investment
China biopharma faces a pause; how bad is it?
China biopharma mid-2023 market summary
Sep 21, 2024
|
4 Min Read
byRichard Daverman, Editor
Illustration, Science word. Business concept for Study of physical world structure behavior Experimental research — Illustration
Innovation
European drug discovery and development players showcase their science at BIO-Europe 2023
European drug discovery and development players showcase their science
Sep 21, 2024
|
8 Min Read
Plenary at BIO-Europe in Munich
Investment
How industry trends are evolving biotech innovation in 2023
2023 industry trends that helped evolve biotech innovation
Sep 21, 2024
|
6 Min Read
photo of a hand holding a globe representing the environment.
Business Strategy
From aspiration to action: navigating sustainability in biopharma
Navigating sustainability in biopharma
Sep 19, 2024
|
5 Min Read
photo of panel at BIO Europe Spring 2024
Partnering
Moving from eminence-based to evidence-based healthcare
Moving from eminence-based to evidence-based healthcare
Sep 19, 2024
|
8 Min Read
BIO-Europe Spring
Partnering
Competitor today, friend tomorrow: Why partnering is critical for biopharma success
Why partnering is critical for biopharma success
Apr 5, 2024
|
4 Min Read
byMillie Nelson, Editor
Clinical Trials Word Cloud illustration
Innovation
Clinical trial innovation at BIO-Europe Spring 2023
Clinical trial innovation at BIO-Europe Spring 2023
Sep 21, 2023
|
6 Min Read

BIO-EUROPE COVERAGE

Novo Nordisk sign
Business Strategy
Lessons and blessings: The Novo Nordisk way
Lessons and blessings: The Novo Nordisk way
Michael May, PhD, President, CCRM discusses Canada as a place for life sciences in this video.
Hubs
Bridging AI & Life Sciences, Why Investing in Canada Should Be Your Next Move
Bridging AI & Life Sciences, Why Investing in Canada Should Be Your Next Move
Shaking hands
Partnering
Picky pharma prone to better proven partners amid dealmaking downturn
Picky pharma prone to better proven partners amid dealmaking downturn
Hervé Ansanay, Biotech Alliance Manager, discusses the features of the RESEAU SATT - SATT NETWORK
Hubs
RESEAU SATT, the Best of French Deep Tech
RESEAU SATT, the Best of French Deep Tech
Jan 13 - Jan 15, 2025
An all-inclusive healthcare conference at Hilton Union Square, San Francisco
Register

Latest

Novo Nordisk logo on a window
Business Strategy
Novo on the ‘ins and outs’ of its nucleic acid growth
Novo on the ‘ins and outs’ of its nucleic acid growth
dollar bills
Investment
JPM 2025: J&J snaps up neuroscience biotech Intra-Cellular for $14.6bn
JPM 2025: J&J snaps up neuroscience biotech Intra-Cellular for $14.6bn
JPM written on wooden blocks in blue
Investment
JPM 2025: GSK shells out $1.15bn to buy oncology firm IDRx
JPM 2025: GSK shells out $1.15bn to buy oncology firm IDRx
Subscribe to Our Newsletters
Stay updated and receive your insights for life sciences investment, innovation and partnering directly in your inbox.
Stay Updated